Serratus Posterior Superior Intekcostal Plane Block vs Serratus Anterior Plane Block for Postoperative Analgesia in VATS: A Randomized Trial"
Launched by SAMSUN UNIVERSITY · Jun 10, 2025
Trial Information
Current as of July 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different methods of pain relief for patients undergoing Video-Assisted Thoracoscopic Surgery (VATS), a type of minimally invasive lung surgery. The trial is comparing the effectiveness of a new pain management technique called the serratus posterior superior intercostal plane block (SPSIPB) with a more established method known as the serratus anterior plane block (SAPB). Both techniques aim to reduce postoperative pain, which can still be significant even with VATS, and help prevent long-term pain issues.
To participate in this study, patients should be between the ages of 18 and 80, with a body mass index (BMI) under 35. They must also be classified as having low to moderate health risks (ASA scores I, II, or III). Patients who have certain medical conditions, a high BMI, or who do not wish to participate will not be included. Those who join the trial can expect to receive one of the two pain relief methods after their surgery and will be monitored for how well it works in managing their pain. This trial is an important step in finding better ways to improve comfort and recovery for patients after lung surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • BMI \< 35 kg/m² Patients with ASA scores I, II, III
- Exclusion Criteria:
- • Patients who do not want to be included in the study Psychiatric and neurological disease with blurred consciousness Patients with ASA \> 3 BMI \> 35 kg/m² Abnormality in coagulation parameters History of allergy to local anesthetic drugs Infection at the injection site Patients whose surgical procedure time exceeds 150 minutes
About Samsun University
Samsun University is a leading academic institution dedicated to advancing medical research and clinical innovation. Committed to improving healthcare outcomes, the university sponsors a range of clinical trials that focus on diverse therapeutic areas. With a robust infrastructure and a team of experienced researchers, Samsun University fosters collaboration between multidisciplinary experts to ensure the highest standards of scientific rigor and ethical compliance. By integrating cutting-edge technology and evidence-based practices, the university aims to contribute valuable insights to the medical community and enhance patient care through its clinical research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Samsun, Ilkadım, Turkey
Samsun, , Turkey
Patients applied
Trial Officials
hamiyet şenol çakmak, specialist
Principal Investigator
samsun university Samsun Training and Research Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported